Press Releases

All seven director nominees electedExecutive changes support Company's growth LEAMINGTON, ON, Nov. 15, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (

CUPERTINO, Calif., Nov. 15, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, President and CEO, will be presenting at the Stifel 2019 Health Care Conference, at the Lotte New York Palace Hotel on Tuesday, November 19, 2019 at 3:35 p.m.

SEATTLE, Nov. 15, 2019 /PRNewswire/ -- RealSelf, the leading resource to research cosmetic treatments and connect with doctors, is bringing its interactive pop-up the

PALO ALTO, Calif., Nov. 15, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management will present a corporate update at the Jefferies 2019 London Healthcare Conference on

NEW YORK, Nov. 15, 2019 /PRNewswire/ -- Belong.Life, creator of the "Belong- Beating Cancer Together" mobile app, the world's largest interactive social network for cancer patients, caregivers and healthcare professionals, has published a study showing that almost half of advanced breast ca

HAIKOU CITY, China, Nov. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter end

ATHENS, Greece, Nov. 15, 2019 /PRNewswire/ -- A second baby has been born via the medical method of Maternal Spindle Transfer, in the context of clinical research being carried out by the scientific team of the 'Institute of Life' and 'Embryotools' in Greece. In the framework of this clinical research, the Maternal Spindle Transfer is bei

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion for Rigel's Marketing Authorization Application (MAA) for fostamatinib disodium hexahydrate (fos

LEXINGTON, Mass., Nov. 15, 2019 /PRNewswire/ -- Promedior, Inc., today announced that it has entered into a definitive merger agreement for Roche (SIX: RO, ROG; OTCQX: RHHBY) to acquire Promedior. With this acquisition, Roche will obtain full rights to Promedior's entire portfolio of molecules for serious fibrotic diseases, notably PRM-151.Promedior, a privately h

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 15, 2019 /PRNewswire/ - Liminal BioSciences Inc. (TSX: LMNL) (OTCQX: PFSCF) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver,